5,000 Shares in SPDR S&P Biotech ETF (NYSEARCA:XBI) Bought by SIH Partners LLLP

SIH Partners LLLP acquired a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) during the fourth quarter, Holdings Channel reports. The fund acquired 5,000 shares of the exchange traded fund’s stock, valued at approximately $450,000.

Several other hedge funds also recently added to or reduced their stakes in the stock. Demars Financial Group LLC acquired a new position in SPDR S&P Biotech ETF in the fourth quarter worth $280,309,000. Mirae Asset Securities USA Inc. lifted its position in shares of SPDR S&P Biotech ETF by 66.7% in the 4th quarter. Mirae Asset Securities USA Inc. now owns 1,500,000 shares of the exchange traded fund’s stock worth $135,090,000 after buying an additional 600,000 shares during the last quarter. Bessemer Group Inc. boosted its holdings in shares of SPDR S&P Biotech ETF by 5.7% in the 4th quarter. Bessemer Group Inc. now owns 1,376,834 shares of the exchange traded fund’s stock valued at $123,997,000 after buying an additional 73,866 shares during the period. Proficio Capital Partners LLC grew its position in shares of SPDR S&P Biotech ETF by 16,156.1% during the 4th quarter. Proficio Capital Partners LLC now owns 917,329 shares of the exchange traded fund’s stock valued at $82,615,000 after buying an additional 911,686 shares during the last quarter. Finally, Employees Retirement System of Texas raised its stake in SPDR S&P Biotech ETF by 33.6% during the fourth quarter. Employees Retirement System of Texas now owns 877,272 shares of the exchange traded fund’s stock worth $79,007,000 after acquiring an additional 220,400 shares during the period.

SPDR S&P Biotech ETF Stock Down 0.6 %

Shares of NYSEARCA XBI opened at $75.51 on Tuesday. The stock has a market capitalization of $4.80 billion, a P/E ratio of 11.47 and a beta of 1.00. The firm’s 50-day moving average price is $83.47 and its two-hundred day moving average price is $90.92. SPDR S&P Biotech ETF has a 52-week low of $66.66 and a 52-week high of $105.47.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.